FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize
[10/02/2024] The U.S. Food and Drug Administration has determined the shortage of tirzepatide injection,...
FDA warns compounders not to use glutathione from Letco Medical to compound sterile drugs
Agency is aware of adverse events related to compounded glutathione injection [2/1/2019] FDA is warning...